Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tempol in COVID-19
NCT04729595Phase 3Terminated
- Sponsor
- DMK Pharmaceuticals Corporation
- Start
- Sep 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tempol in coronavirus disease 2019 (COVID-19), sponsored by DMK Pharmaceuticals Corporation. Started Sep 2021; status: terminated.
02
Drugs
tempol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04729595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04729595.